AI-generated summary
The authors reviewed 72 studies on photobiomodulation for bowel disease, of which 9 focused on inflammatory bowel disease. They report that the IBD studies, mostly in rats, showed reduced intestinal inflammation, improved mucosal integrity and modulated immune response. They found no clinical studies sufficient to establish effective and safe treatment protocols.
- Studies included
- 9
- Who or what was studied
- Studies of inflammatory bowel disease (ulcerative colitis and Crohn's disease), mainly experimental studies in rats
- Limits stated in the abstract
- Evidence is mostly preclinical in rats, with only one clinical protocol and no clinical studies found to establish treatment protocols.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.